LIGAND PHARMACEUTICALS INCORPORATED Available-for-sale Securities
LIGAND PHARMACEUTICALS INCORPORATED (LGNDZ) had Available-for-sale Securities of $213.33 million as of 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2018-05-09
- 2018-03-31: Available-for-sale Securities $213.33M.
- 2017-12-31: Available-for-sale Securities $181.04M.
- 2017-09-30: Available-for-sale Securities $169.52M.
- 2017-06-30: Available-for-sale Securities $112.40M.
| Period end | Available-for-sale Securities |
|---|---|
| 2018-03-31 | $213.33M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $181.04M 10-Q · filed 2018-05-09 |
| 2017-09-30 | $169.52M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $112.40M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $148.73M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $122.30M 10-Q · filed 2017-11-09 |
| 2016-09-30 | $37.53M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $45.60M 10-Q · filed 2016-11-14 |
| 2016-03-31 | $81.91M 10-Q · filed 2016-11-14 |
| 2015-12-31 | $102.79M 10-Q · filed 2016-11-14 |
| 2015-09-30 | $94.13M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $73.97M 10-Q · filed 2015-08-05 |
| 2014-12-31 | $8.39M 10-K · filed 2016-11-14 |